Skip to content

Prediction of Outcome in Severe Preeclampsia

Relation of 3rd Trimester Uterine Artery Doppler Flow Velocimetry Indices, Factor V Leiden Mutation and Placental Pathology to the Severity of Preeclampsia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03871764
Enrollment
100
Registered
2019-03-12
Start date
2015-12-01
Completion date
2017-04-30
Last updated
2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Doppler Examination, Leiden Factor V Deficiency,Preeclampsia, Palental Pathology

Brief summary

this summary studied the predictive values of factor V Leiden mutation , doppler indices , placental pathology to unfavorable fetal and maternal outcomes

Detailed description

leiden mutation is activated protein C resistance with hypercoagulable states and increased thrombotic risk. 99 % are heterozygous and 1 % is homozygous , very rare cases are psoudohomozygous with factor V deficiency. relation to this mutation was studied in severe preeclamptic patients. doppler indices of uterine arteries , increased pulsetility index or unilateral or bilateral uterine artery notch and placental pathology were studied.

Interventions

DIAGNOSTIC_TESTblood sample , doppler of uterine vessel and placenta

blood sample for factor V and doppler examination of uterine arteries , placenta pathology post partum

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

severe preeclampsia in 3rd trimester -

Exclusion criteria

Twin pregnancy. Fetal congenital anomalies. Diabetic patient, impaired renal function. Any medical disorders even that HTN. Any placental pathology,Autoimmune diseases. Women with uterine activity or clinical emergencies with maternal hemodynamic instability or an indication for immediate termination of pregnancy. \-

Design outcomes

Primary

MeasureTime frameDescription
percentage of patients develop abruption placenta, intrauterine growth retardation or delivered prematurewithin 12 wks from diagnosis of severe preeclampsiaplacental abruption, prematurity, IUGR
percentage of fetuses and neonates complicated with intrauterine fetal death or need admission to incubatorfrom diagnosis of severe preeclampsia till one week after deliveryIUFD, admission to neonatal IUC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026